Teva UK Ltd v Janssen Pharmaceutica NA: PatC 16 Nov 2020

First case management conference in a claim for a declaration that a Supplementary Protection Certificate is invalid and should be revoked.
[2020] EWHC 3157 (Pat)
Bailii
England and Wales

Updated: 22 February 2021; Ref: scu.657796